| Wednesday 9 April
|
|
07:15 08:00
|
|
Clinical Expert 3: Peri-operative care of phaeos
Supported by Clinical Endocrinology
Queen's Suite 1
Chair: M Serpell (Glasgow)
M Serpell (Glasgow)
|
| |
|
|
|
07:15 08:00
|
|
Clinical Expert 4: Thyroid disease in pregnancy
Supported by Clinical Endocrinology
Queen's Suite 2
Chair: G Brabant (Manchester)
J Lazarus (Cardiff)
|
| |
|
|
|
08:10 08:55
|
|
Society for Endocrinology Annual General Meeting
Main Auditorium
|
| |
|
|
|
09:00 11:00
|
|
Symposium 6: The endocrinology of critical illness
Main Auditorium
Chairs: P Stewart (Birmingham) & S Ball (Newcastle-upon-Tyne)
|
| 09.00 |
S28
|
Critical illness: an overview of the physiological and metabolic changes
S Baudouin (Newcastle-upon-Tyne)
|
| 09.30 |
S29
|
The glucocorticoid axis in critical illness: cause or effect?
M Cooper (Birmingham)
|
| 10.00 |
S30
|
Thyroid hormone axis in critical illness
S Ball (Newcastle-upon-Tyne)
|
| 10.30 |
S31
|
Insulin and blood glucose changes in critical illness
G Van den Berghe (Leuven, Belgium)
|
| |
|
|
|
09:00 11:00
|
|
Symposium 7: Evolving endocrine targets for C-type natriuretic peptide (CNP)
Queen's Suite 2
Chairs: C McArdle (Bristol) & K Jonas (London)
|
| 09.00 |
S32
|
Emerging Roles for CNP
E Espiner (Christchurch, New Zealand)
|
| 09.30 |
S33
|
The new biology of pituitary natriuretic peptides: novel signalling from guanylyl cyclase-B (GC-B) receptors
R Fowkes (London)
|
| 10.00 |
S34
|
New aspects of CNP function
R Middendorff (Giessen, Germany)
|
| 10.30 |
S35
|
Noval cardiovascular roles for CNP
C Villar (London)
|
| |
|
|
|
09:00 11:00
|
|
Nurse session 1: Cushing's Syndrome
Queen's Suite 1
Chairs: A Marland (Oxford) & J MacDonald (Oxford)
|
| 09.00 |
S57
|
Overview and diagnosis
J Bevan (Aberdeen)
|
| 09.30 |
S58
|
Cushing's: the worst case scenario
V Thornton-jones (Oxford)
|
| 10.00 |
S59
|
A case of cyclical Cushing's Syndrome?
V Kieffer (Leicester)
|
| 10.30 |
S60
|
Cushing's Syndrome - a success story?
S Cox (Torquay)
|
| |
|
|
|
11:00 11:30
|
|
Coffee
Hall Q
|
| |
|
|
|
11:30 12:05
|
|
Society for Endocrinology European Medal Lecture
Main Auditorium
Chair: J Buckingham (London)
|
|
S3
|
Testicular dysgenesis syndrome (TDS): clinical and environmental aspects
N Skakkebaek (Copenhagen, Denmark)
|
| |
|
|
|
12:05 12:40
|
|
Society for Endocrinology Asia and Oceania Medal Lecture
Main Auditorium
Chair: J Wass (Oxford)
|
|
S4
|
Unraveling the metabolic mysteries regulating body composition: new insights into old hormones
K Ho (Sydney, Australia)
|
| |
|
|
|
12:40 14:15
|
|
Lunch
Hall Q
|
| |
|
|
|
13.00 13.45
|
|
Attended posters
Hall Q
|
| |
|
|
|
14:15 16:15
|
|
Symposium 8: Inflammation and the adipocyte – integrated pathways that regulate disease risk
Queen's Suite 2
Chairs: K Chapman (Edinburgh) & N Fernandes da Silva (Warwick)
|
| 14.15 |
S36
|
Leptin as a proinflammatory cytokine
G Lord (London)
|
| 14.45 |
S37
|
Nuclear receptors and regulation of inflammatory pathways
B Staels (Lille, France)
|
| 15.15 |
S38
|
Anti-inflammatory and pro-resolution lipid mediators: lessons for obesity-related inflammation.
D Gilroy (London)
|
| 15.45 |
S39
|
Adipose tissue and chronic inflammation
S Kumar (Warwick)
|
| |
|
|
|
14:15 16:15
|
|
Clinical Mangement Workshop 3: Managing the obese patient
Supported by Clinical Endocrinology
Main Auditorium
Chairs: R Murray (Leeds) & S Aylwin (London)
|
| 14.15 |
S50
|
Managing the obese patient: lifestyle intervention and prescriptive exercise
R Andrews (Bristol)
|
| 14.45 |
S51
|
Obesity management – the role of drugs in the 21st Century
J Wilding (Liverpool)
|
| 15.15 |
S52
|
New insulins - suck 'em and see!
A Robinson (Bolton)
|
| 15.45 |
S53
|
Role of bariatric surgery
S Aylwin (London)
|
| |
|
|
|
14:15 16:15
|
|
Nurse session 2: Diabetes insipidus
Queen's Suite 1
Chairs: V Kieffer (Leicester) & V Thornton-Jones (Oxford)
|
| 14.15 |
S61
|
Overview and how to do a water deprivation test: interpretation of results
J Wass (Oxford)
|
| 14.55 |
S62
|
Water deprivation test: a ‘real’ case
M O' Connor (Oxford)
|
| 15.35 |
S63
|
Water deprivation test: a 'red herring' case
J MacDonald (Oxford)
|
| |
|
|
|
16:15 16:45
|
|
Tea
Hall Q
|
| |
|
|
|
16:15 16:45
|
|
Nurses Tea
Generously supported by Ipsen Ltd
Conference Suite
|
| |
|
|
|
16:45 17:05
|
|
Awards ceremony
Main Auditorium
Chair: J Wass (Oxford)
|
| |
|
|
|
17:05 17:40
|
|
British Thyroid Association Pitt-Rivers Lecture
Supported by the Clinical Endocrinology Trust
Main Auditorium
Chair: A Weetman (Sheffield)
|
|
S5
|
Thyroid hormone receptors, mutations, and cancer development
S Cheng (Bethesda, USA)
|
| |
|
|
|
17:40 18:15
|
|
Clinical Endocrinology Visiting Professor Lecture
Supported by the Clinical Endocrinology Trust
Main Auditorium
Chair: A Weetman (Sheffield)
|
|
S6
|
Inappropriate secretion of TSH
P Beck-Peccoz (Milan, Italy)
|
| |
|
|
|
18:15 18:45
|
|
PCOS satellite reception
A buffet will be sereved for those attending the satellite
Generously supported by Almirall Ltd
Upper foyer
|
| |
|
|
|
18:15 18:45
|
|
Neuroendocrine Tumours Satellite reception
A buffet will be available for those attending the satellite
Generously supported by Novartis
Queen's Suite foyer
|
| |
|
|
|
18:45 20:45
|
|
PCOS and Metabolic Syndrome Special Interest Group Satellite: Advances in PCOS in the last 12 months
Generously supported by Almirall Ltd
Main Auditorium
Chairs: S Atkin (Hull) & H Randeva (Warwick)
|
| 18.45 |
|
An update and highlights of the basic science advances of PCOS
H Randeva (Warwick)
|
| 19.15 |
|
An update and highlights of the reproductive aspects of PCOS
A Balen (Leeds)
|
| 19.45 |
|
An update and highlights of the cosmetic aspects of PCOS
A Layton (Harrogate)
|
| 20.15 |
|
Discussion
|
| |
|
|
|
18:45 20:45
|
|
Neuroendocrine Tumours Satellite
Generously supported by Novartis
Queen's Suite 1
Chairs: D O'Shea (Dublin, Ireland) & K Meeran (London)
|
| 18.45 |
|
Clinical case discussions and current clinical trials for neuroendocrine tumours
K Meeran (London) & J Newell-Price (Sheffield)
|
| 19.15 |
|
Diagnostic and treatment algorithm for neuroendocrine tumours
D O'Shea (Dublin, Ireland)
|
| 19.45 |
|
Mechanisms underlying neuroendocrine tumourigenesis and development of models
R Thakker (Oxford)
|
| 20.15 |
|
Tumour targetted radioactive treatment of neuroendocrine tumours
D Kwekkeboom (Rotterdam, The Netherlands)
|
| |
|
|